BioSpace News Archive

Drug Development

ReShape Lifesciences Announces European Trial to Support CE-Mark of ReShape Vest

ReShape Lifesciences Inc. announced the Company has commenced site initiation training for the first clinical trial site that will participate in the multi-center trial of the ReShape VestTM to support CE Mark approval.

July 31, 2018
·
5 min read
Biotech Bay

Second Genome Certified as Great Place to Work®

Second Genome, Inc. was certified as a great workplace last week by the independent analysts at Great Place to Work®.

July 31, 2018
·
3 min read
Business

Aldeyra Therapeutics Appoints Joshua Reed as Chief Financial Officer

Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), today announced the appointment of Joshua Reed as Chief Financial Officer.

July 31, 2018
·
6 min read
Policy

Eiger BioPharmaceuticals Announces Notice of Allowance for U.S. Patent Covering a Broad Range of Ritonavir-Boosted Lonafarnib Dosing Regimens for Treatment of Hepatitis Delta Virus Infection

Eiger BioPharmaceuticals, Inc. announced that it has received the Notice of Allowance from the United States Patent and Trademark Office (USPTO) for U.S. patent application number 15/335,327, entitled “Treatment of Hepatitis Delta Virus Infection.”

July 31, 2018
·
5 min read
Business

Sensus Healthcare CEO Receives “Innovator of the Year” Award at The Aesthetic Show 2018

Sensus Also Named Runner-Up “Company Innovator of the Year”

July 31, 2018
·
6 min read
Business

Semler Reports Second Quarter and First Half 2018 Financial Results

Continued Growth in Revenues and Earnings

July 31, 2018
·
13 min read
Policy

Indivior Preliminary Injunction on Generic (buprenorphine and naloxone) Sublingual Film Upheld

Company will continue to vigorously defend our SUBOXONE® (buprenorphine and naloxone) Sublingual Film intellectual property

July 31, 2018
·
8 min read
Policy

European Patent Granted for Biocept’s Target Selector Oncogene Mutation Enrichment and Detection Platform

Expands intellectual property to 27 issued patents globally for highly sensitive methods of detecting cancer biomarkers in circulating tumor DNA (ctDNA) and on circulating tumor cells (CTCs)

July 31, 2018
·
5 min read
Business

Thomas W. Burns, CEO of Glaukos, Joins Avedro’s Board of Directors

Avedro, Inc. today announced that Thomas W. Burns has been elected to its Board of Directors.

July 31, 2018
·
2 min read
Business

10x Genomics Partners with BioLegend and Immudex to Extend Research Applications of Its New Single Cell Feature Barcoding Technology

The newly developed applications have potential to accelerate disease research and drug discovery in oncology, neurology, infections disease, and immunology in addition to enhancing cell atlas research initiatives.

July 31, 2018
·
5 min read